Pfizer Will Charge Patients $1,390 for COVID Anti-Viral Paxlovid
Pfizer, Inc. plans to charge consumers more than double the price charged to the U.S. government for its COVID-19 anti-viral drug nirmatrelvir-ritonavir, sold under the brand name Paxlovid. A five-day course of the drug to treat COVID will soon cost patients $1,390. According to researchers, it costs Pfizer $13 to manufacture the supply of pills […]
U.S. Vaccine Industry Harvesting Blood from Horseshoe Crabs
For many decades, the blue colored blood from horseshoe crabs has been harvested for purposes of medical research and for quality control and safety testing in vaccines, prosthetics and intravenous drugs. Their eggs are also a staple food for a shorebird bird known as the red knot, which is listed as threatened under the Endangered […]
Private Equity Buyouts of Health Care Facilities Comes With Cost to Patients
The rising trend in burnout of health care workers in recent years has presented an opportunity for private equity corporations in the United States to invest in the health care market at record high rates.1 For several decades, multibillion-dollar corporate giants have been gaining control of many sectors of American society, including the food industry […]
Los Angeles School District Encourages Sick Students to Attend Classes
When Los Angeles Unified School District (LAUSD) in California reopened following the end of the COVID-19 public health emergency (PHE) declaration, public school officials initially demanded that parents keep students at home if they showed even the slightest symptoms of illness.1 At one time, LAUSD had the strictest COVID-19 protocols in the United States, which […]
EcoHealth Alliance Sued by Families for Funding Chinese Institute Linked to Mutant SARS-CoV-2
Family members of four people who died from COVID-19 are suing the New York-based non-profit EcoHealth Alliance and its president, Peter Daszak, for funding and collaborating with the Wuhan Institute of Virology (WIV) in China. Since 2020, there have been allegations that the Chinese biohazard research facility is responsible for a lab leak that released […]
Novavax to Receive $350 Million for Cancelled COVID Vaccine Orders in Canada
According to a securities filing with the U.S. Securities and Exchange Commission (SEC) by Novavax Inc. of Gaithersburg, Maryland on June 30, 2023, the government of Canada will pay the company $349.6 million to settle the forfeiting of doses of its Nuvaxovid recombinant protein COVID-19 vaccine previously ordered and scheduled for delivery.1 2 Nuvaxvoid was […]
